An analysis of HTA and reimbursement procedures in EUnetHTA partner countries: final report
Medicines regulator and network of Health Technology Assessment (HTA) bodies continue to strengthen their collaboration
Final project plan for Other Technologies CA on MammaPrint® - Added value of using gene-expression signature for adjuvant chemotherapy decisions in early breast cancer assessment (OTCA04)
Final project plan for Other Technologies TAVI